This Guidance Note is intended to be an introduction into the Base Erosion and Profit Shifting (“BEPS”), particularly, into how the OECD BEPS initiatives are most likely to impact Life Science companies in the UK.

Rather than providing an overview of all 15 actions, this Note focusses on Actions 7, 8-10 and 13.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.